4//SEC Filing
Rajavelu Esther 4
Accession 0000899243-22-001475
CIK 0001680581other
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 4:30 PM ET
Size
5.5 KB
Accession
0000899243-22-001475
Insider Transaction Report
Form 4
Rajavelu Esther
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2022-01-03+200,000→ 200,000 totalExercise: $17.82Exp: 2032-01-02→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]This option was granted on January 3, 2022 and is scheduled to vest 25% on the first anniversary of the vesting commencement date of January 3, 2022. The remainder of the shares underlying the grant shall vest in equal quarterly installments over the following three years until the fourth anniversary of the vesting commencement date, subject to continued service.
Documents
Issuer
Fulcrum Therapeutics, Inc.
CIK 0001680581
Entity typeother
Related Parties
1- filerCIK 0001903716
Filing Metadata
- Form type
- 4
- Filed
- Jan 9, 7:00 PM ET
- Accepted
- Jan 10, 4:30 PM ET
- Size
- 5.5 KB